Lifecore Biomedical LFCR
NASDAQ LFCR
$4.52 +0.06 (+1.35%)
At close: Aug 20, 2026 · 4:00 PM EDT

Lifecore Biomedical, Inc. \De\ (LFCR) Asset Utilization Ratio (2011 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) posted quarterly Asset Utilization Ratio of 0.54 for Q2 2025, up 5.35% year-over-year from 0.51 in Q2 2024, and up 2.22% quarter-over-quarter from 0.53 in Q1 2025.

Lifecore Biomedical, Inc. \De\ (LFCR) Asset Utilization Ratio (2011 - 2025) Analysis & Trends

Lifecore Biomedical, Inc. \De\'s Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.54 for Q2 2025.

  • In Q2 2025, Asset Utilization Ratio rose 5.35% year-over-year to 0.54; the TTM figure through May 2025 stood at 0.54 (up 5.35% YoY), while the FY2025 annual figure was 0.52, up 3.37% from the prior year.
  • Asset Utilization Ratio for Q2 2025 stood at 0.54, up from 0.53 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.54 in Q2 2025, with the low at 0.24 in Q2 2021.
  • The 5-year median for Asset Utilization Ratio is 0.42 (2023), against an average of 0.42.
  • The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio sank 83.12% in 2021, then jumped 65.85% in 2022.
  • Lifecore Biomedical, Inc. \De\'s Asset Utilization Ratio stood at 0.28 in 2021, then surged by 44.16% to 0.4 in 2022, then increased by 13.83% to 0.46 in 2023, then rose by 13.97% to 0.52 in 2024, then rose by 3.67% to 0.54 in 2025.
  • Business Quant data shows LFCR's Asset Utilization Ratio at 0.54 in Q2 2025, 0.53 in Q1 2025, and 0.52 in Q4 2024.

Peer Comparison

Historic Data

Download Data
DateValue
May 25, 2025 0.54
Feb 23, 2025 0.53
Nov 24, 2024 0.52
Aug 25, 2024 0.51
May 26, 2024 0.51
Feb 25, 2024 0.49
Nov 26, 2023 0.46
Aug 27, 2023 0.42
May 28, 2023 0.42
Feb 26, 2023 0.39
Nov 27, 2022 0.40
Aug 28, 2022 0.42
May 29, 2022 0.37
Feb 27, 2022 0.34
Nov 28, 2021 0.28
Aug 29, 2021 0.25
May 30, 2021 0.24
Feb 28, 2021 0.46
Nov 29, 2020 0.71
Aug 30, 2020 1.19